Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04836455 · ClinicalTrials.gov registry record · NA
Impact of Vaping Prevention Advertisements
A NA study of Vaping, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,565
- Enrollment target
- 1
- Study location
NCT04836455: Completed NA study of Vaping, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT04836455 is a NA study of Vaping that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,565 participants, above the 674-participant average among 18 other Vaping trials with a reported enrollment target (132% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04836455, a NA study of Vaping, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,565 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the repeated exposures to ads that people have in the real world. This study addresses this issue by repeatedly exposing participants to vaping prevention ads over time. Participants will be adolescents aged 13-17 who currently vape or who are susceptible to vaping. Participants will be randomly assigned to ad stimuli. They will be assigned to one of two The Real Cost trial arms-health harms or addiction-or to a control trial arm (probability of assignment is 1/3 for all trial arms). Participants in the study will take 4 online surveys over a 3-week period, once per week (At week 0, 1, 2, and 3). All participants will view randomized ad stimuli based on their trial arm and answer surveys items at each session.
Primary Outcome
The 3-item Susceptibility to Vaping Scale assesses the extent to which adolescents are open to vaping, using a 1 to 4 response option scale. Here, 1 indicates the lowest susceptibility to vaping, and 4 represents the highest, with higher values indicating a greater susceptibility to vaping - essentially, a worse outcome. The overall scale score is determined by averaging the scores of the three items, summing these scores and dividing by 3. This method results in a score range from a minimum of
Conditions Studied
Interventions
- BEHAVIORAL The FDA's The REal Cost vaping prevention ads - Health harms theme
- BEHAVIORAL The FDA's The Real Cost vaping prevention ads - Addiction theme
- BEHAVIORAL Neutral vaping ads
Study Locations (1)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,565 participants |
| Start Date | 2021-07-03 |
| Est. Completion | 2021-11-03 |
| Phase | NA |
What the finished NCT04836455 record still lists
NCT04836455 is an interventional study that assigns participants to a tested intervention. Its 1,565 participants enrollment target places it among the larger protocols in the corpus, above the 674-participant average among 18 other Vaping trials with a reported enrollment target (132% higher).
The record links to 1 condition, with Vaping appearing as the primary indexed condition, and to 3 interventions - of which The FDA's The REal Cost vaping prevention ads - Health harms theme is the first listed.
NCT04836455 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04836455 about?
NCT04836455 is a clinical study titled "Impact of Vaping Prevention Advertisements". The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the rep...
What is the current status of trial NCT04836455?
This trial is currently completed. It is a NA study. The enrollment target is 1,565 participants. The study started on 2021-07-03. Estimated completion is 2021-11-03.
What conditions does trial NCT04836455 study?
This clinical trial studies the following conditions: Vaping.
What interventions are being tested in trial NCT04836455?
The interventions under investigation include: The FDA's The REal Cost vaping prevention ads - Health harms theme (BEHAVIORAL), The FDA's The Real Cost vaping prevention ads - Addiction theme (BEHAVIORAL), Neutral vaping ads (BEHAVIORAL).
Who is sponsoring clinical trial NCT04836455?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04836455 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04836455's enrollment target sits among peer trials
1,565 4th of 18 higher than 15 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI